The effectiveness of phage therapy in infections caused by staphylococcus aureus: a meta-analysis of clinical studies
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
Abstract
The aim of this meta-analysis was to evaluate the efficacy of phage therapy for Staphylococcus aureus infections by examining the results of clinical trials as part of the antibiotic resistance improvement. Data from 19 studies that used phages as monotherapy or in combination with antibiotics were included. The data was collected for the period 2005-2025 using analysis of medical records.
Article Details
References
Kaixin Liu. Bacteriophage therapy for drug-resistant Staphylococcus aureus infections. – China, 2024. – p.1. doi: 10.3389/fcimb.2024.1336821. DOI: https://doi.org/10.3389/fcimb.2024.1336821
Ryszard Międzybrodzki. Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment. – Poland, 2007. – p. 461. PMID: 17679835.
Rodriguez J. M. Case Report: successful use of phage therapy in refractory MRSA chronic rhinosinusitis. – USA, 2022. – p. 14. doi: 10.1016/j.ijid.2022.04.049. DOI: https://doi.org/10.1016/j.ijid.2022.04.049
Zhvania P. Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome. – Georgia, 2017. – p. 1. doi: 10.3389/fmed.2017.00094. DOI: https://doi.org/10.3389/fmed.2017.00094
Johri A.V. Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments. – Georgia, 2021. – p. 1. doi: 10.3389/fphar.2021.692614. DOI: https://doi.org/10.3389/fphar.2021.692614
Daniela I. Munteanu. Phage Therapy for Orthopaedic Infections: The First Three Cases from the United Kingdom. – United Kingdom, 2025. – p. 1. doi: 10.3390/antibiotics14020114. DOI: https://doi.org/10.3390/antibiotics14020114
PetrovicFabijan A. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. – Australia, 2020. – p. 465. doi: 10.1038/s41564-020-0698-9. DOI: https://doi.org/10.1038/s41564-019-0634-z
Young M. J. Phage Therapy for Diabetic Foot Infection: A Case Series. – United Kingdom, 2023. – p. 797. doi: 10.1016/j.clinthera.2023.06.009. DOI: https://doi.org/10.1016/j.clinthera.2023.06.009
Aslanov A.B. Bacteriophages for controlling outbreaks caused by Staphylococcus aureus in neonatal intensive care units. – Russia, 2015. – 116 p. УДК 614.21-036.882-053.31:614.4.
Ooi M.L. Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus. – Australia, 2019. –
p. 723. doi: 10.1001/jamaoto.2019.1191. DOI: https://doi.org/10.1001/jamaoto.2019.1191
Priputnevich T.V. Use of a gel with bacteriophages for nasopharyngeal sanitation in carriers of Staphylococcus aureus among the staff of a maternity facility. – Russia, 2016. – p. 111. doi: 10.18565/aig.2016.3.111-115. DOI: https://doi.org/10.18565/aig.2016.3.111-115
Ramirez-Sanchez C. Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy. – USA, 2021. – p. 1. doi: 10.3390/v13061182. DOI: https://doi.org/10.3390/v13061182
Ferry T. Phage Therapy as Adjuvant to Conservative Surgery and Antibiotics to Salvage Patients with Relapsing S. aureus Prosthetic Knee Infection. – France, 2020. – p. 1. doi: 10.3389/fmed.2020.570572. DOI: https://doi.org/10.3389/fmed.2020.570572
Rose T. Experimental phage therapy of burn wound infection: difficult first steps. – Belgium, 2014. – p. 66. ISSN:2160-2026/IJBT0001948. PMID: 25356373. PMCID: PMC4212884.
Leszczyński P. Successful eradication of methicillin-resistant Staphylococcus au-reus (MRSA) intestinal carrier status in a healthcare worker — Case report. – Poland, 2006. – p. 236. doi: 10.1007/BF02932128. DOI: https://doi.org/10.1007/BF02932128
Gilbey T. Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus. – Australia, 2019. –
p. 142. doi: 10.5694/mja2.50274. DOI: https://doi.org/10.5694/mja2.50274
Doub J.B. Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection. – USA, 2020. – p. 1. doi: 10.3390/antibiotics9050241. DOI: https://doi.org/10.3390/antibiotics9050241
Fadlallah A. Corneal Infection Therapy with Topical Bacteriophage Administration. – France, 2015. – p. 167. doi: 10.2174/1874364101509010167. DOI: https://doi.org/10.2174/1874364101509010167
Wahl P. Bacteriophage therapy created the necessary conditions for successful an-tibiotic suppression in a periprosthetic hip joint infection: a Case Report. – Switzerland, 2025. – p. 1. doi: 10.3389/fmed.2025.1564369. DOI: https://doi.org/10.3389/fmed.2025.1564369
Ferry T. Salvage Debridement, Antibiotics and Implant Retention ("DAIR") With Local Injection of a Selected Cocktail of Bacteriophages: Is It an Option for an Elderly Patient With Relapsing Staphylococcus aureus Prosthetic-Joint Infection – France, 2018. – p. 1. doi: 10.1093/ofid/ofy269. DOI: https://doi.org/10.1093/ofid/ofy269